|LETTER TO THE EDITOR
|Year : 2020 | Volume
| Issue : 2 | Page : 227-228
Commentary on “Transurethral seminal vesiculoscopy for recurrent hemospermia: experience from 419 cases”
Kun Pang, Bing-Zheng Dong, Cong-Hui Han
Department of Urology, Xuzhou Central Hospital, Xuzhou Clinical College Affiliated to Xuzhou Medical University, Xuzhou 221009, China
|Date of Submission||03-Dec-2018|
|Date of Acceptance||25-Feb-2019|
|Date of Web Publication||11-Jun-2019|
Department of Urology, Xuzhou Central Hospital, Xuzhou Clinical College Affiliated to Xuzhou Medical University, Xuzhou 221009
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Pang K, Dong BZ, Han CH. Commentary on “Transurethral seminal vesiculoscopy for recurrent hemospermia: experience from 419 cases”. Asian J Androl 2020;22:227-8
|How to cite this URL:|
Pang K, Dong BZ, Han CH. Commentary on “Transurethral seminal vesiculoscopy for recurrent hemospermia: experience from 419 cases”. Asian J Androl [serial online] 2020 [cited 2020 Apr 2];22:227-8. Available from: http://www.ajandrology.com/text.asp?2020/22/2/227/259996 - DOI: 10.4103/aja.aja_56_19
We have read the article by Chen et al. with great interest. They reported the effect of transurethral seminal vesiculoscopy (TSV) for the treatment of recurrent hemospermia, and they concluded that TSV was an effective and safe procedure in the management of seminal tract disorders. TSV is an endoscopic technique that has developed rapidly in recent years. Because it is a relatively simple procedure and does not change the normal anatomical structures of seminal vesicles, this technique is becoming an alternative for the diagnosis and treatment of seminal vesicle and seminal tract diseases.,
Recently, we found that TSV is having a tendency to abuse in China. We have found that there have been issues with low qualification operator-related complications and failures in China recently. Some primary hospitals, even those have just settled ureteroscopy, have begun to plan a TSV surgery. Our department, as a Grade 3 hospital, has used TSV to treat 48 patients from January 2013 to July 2016. They were not able to locate the ejaculatory duct opening in some cases, which led to surgical failures. In addition, we have identified other complications, such as epididymitis, urinary tract infection, ejaculation abnormality, continuous hematuria, and rectal injury of clinical symptoms. The main reason may be related to the surgeon's dependence on ureteroscopy, neglecting the uniqueness of TSV surgery.
The anatomical structures may not be sufficiently visible during this kind of procedure, resulting in poor outcomes, relatively low spousal pregnancy rates, and postoperative complications rates of approximately 13%–26%. This procedure has the following disadvantages: (a) it may induce an injury to the rectum, and it may lead to retrograde ejaculation, caused by the destruction of the local antireflux mechanism, reflux seminal vesiculitis, or epididymitis; (b) after the normal structures and physiological functions of the ejaculatory duct and seminal vesicle are destroyed, the reserve function of the seminal vesicles decreases, the pH value of the semen changes, and the sperm motility and fertilization capacity decline; (c) the seminal vesicle fullness weakens and male sexual function decreases; and (d) when the endoscope is inserted via a nonnatural channel, the seminal tract may be injured and postoperative scar traction may occur, leading to recurrent local obstruction of the seminal tract, which may be the primary cause of the high rate of postoperative recurrence. For these reasons, we performed a transurethral resection of the ejaculatory duct opening only when the prostatic utricle could not be found or the trans-window procedure failed. Unfortunately, there was no significant reduction in the incidence of complications.
According to the anatomical data reported by Nguyen et al., the normal size of the ejaculatory duct opening is only 0.3 ± 0.1 mm. The repeated stimulation of tissues that have chronic inflammation, congenital or acquired cystic lesions in the ejaculatory duct area, or other factors may lead to stenosis or atresia of the ejaculatory duct opening. In addition, poor semen excretion can also produce seminal tract stones and persistent chronic inflammation, and this situation makes it difficult to insert the endoscope via the natural pathway. In such situations, some scholars recommend using transurethral resection of the ejaculatory duct opening, and others recommend using the open-window procedure via the 5 and 7 o'clock points at the bottom of the prostatic utricle.,, At present, there is no uniform standard for this technique. The outer layer of the ejaculatory duct is longitudinal smooth muscle. At the proximal end, it becomes thin rapidly, and the inner smooth muscle disappears. Therefore, the ejaculatory duct has no sphincter functions, such as peristalsis or contraction, and urinary reflux is prevented only by the presence of the sharp angle between the ejaculatory duct and the prostatic urethra. An experiment in animals found that the relationship between the seminal vesicle and the ejaculatory duct was similar to that between the bladder and the urethra. When we make a hole to enter the ejaculatory duct, it is in theory a false channel; if the size of the hole is too large, it may result in reflux, and if the hole size is too small, it may induce recurrent stenosis or even occlusion after surgery.
During our following surgeries, we used Storz F4.5–F6.5 ureteroscopes for patients with small ejaculatory duct openings and distorted or narrow seminal tracts, and we found that ultrathin ureteroscopes can pass smoothly into the ejaculatory duct. Therefore, we recommend these or similar endoscopes to increase the success rate and to minimize injuries to surrounding tissues. However, surgeons should be aware that TSV can still damage the seminal tract because of complex causes, such as the soft textures and distorted structures of the seminal colliculus, ejaculatory duct, and seminal vesicles. Accordingly, surgeons should practice carefully after careful study of the anatomy of the seminal vesicles and seminal tract.
In summary, we recommend that sufficient attention be paid to the following issues. First, some patients presented no special abnormal findings when we performed TSV, but clinical symptoms did not disappear after surgery. The seminal vesicle was honeycomb shaped, with obvious segmentation, in the cross-sections. Therefore, we could not observe the entire seminal vesicle during surgery and may have missed some lesions, including local bleeding and small stones. This is caused by the normal anatomical structure of the seminal vesicle and is a limitation of TSV. Second, even if the lesion was located in only one side of the seminal vesicle, we nonetheless imaged both sides routinely, to prevent misdiagnosis, mistreatment, and symptom recurrence. Experts have different opinions regarding whether bilateral endoscopic examination is necessary, and a large-scale data analysis is required to settle the issue. Third, if surgeons fail to enter the seminal vesicle, surgery should be terminated promptly to avoid accidental injury. TSV can identify the seminal tract and seminal vesicle diseases only in the distal area; however, it cannot explore the entire seminal vesicle and seminal tract. Some lesions are located in the proximal areas of the seminal tract and seminal vesicle and cannot be treated by this technique. This is an anatomical limitation of the technique.
As a new surgical procedure, TSV still has some limitations. It should develop a unified judgment standard by the Urology Branch of Chinese Medical Association to assess the qualifications of local hospitals to carry out the operation, so as to avoid further abuse in China. We believe that TSV will have a better future with the development of new minimally invasive endoscopic instruments and the improvement of qualification review standards.
| Author Contributions|| |
KP wrote the manuscript and complete data collection, BZD was responsible for the planning of the research, CHH supervised this project. All authors read and approved the final manuscript.
| Competing Interests|| |
All authors declared no competing interests.
| References|| |
Chen R, Wang L, Sheng X, Piao SG, Nian XW, et al.
Transurethral seminal vesiculoscopy for recurrent hemospermia: experience from 419 cases. Asian J Androl
2018; 20: 438–41.
Han CH, Liang Q, Dong BZ, Hao L, Fan T, et al.
The transurethral seminal vesiculoscopy in the diagnosis and treatment of the seminal vesicle disease. Cell Biochem Biophys
2013; 66: 851–3.
Song T, Zhang X, Zhang L, Zhang F, Fu WJ. Transurethral seminal vesiculoscopy in the diagnosis and treatment of seminal vesicle stones. Chin Med J
2012; 125: 1475–8.
El-Assmy A, El-Tholoth H, Abouelkheir RT, Abou-El-Ghar ME. Transurethral resection of ejaculatory duct in infertile men: outcome and predictors of success. Int Urol Nephrol
2012; 44: 1623–30.
Cheng G, Liu B, Song Z, Xu A, Song N, et al.
A novel surgical management for male infertility secondary to midline prostatic cyst. BMC Urol
2015; 15: 18.
Heshmat S, Lo KC. Evaluation and treatment of ejaculatory duct obstruction in infertile men. Can J Urol
2006; 13 Suppl 1: 18–21.
Li BJ, Zhang C, Li K, Zhang J, Zhang Y, et al.
Clinical analysis of the characterization of magnetic resonance imaging in 102 cases of refractory haematospermia. Andrology
2013; 1: 948–56.
Nguyen HT, Etzell J, Turek PJ. Normal human ejaculatory duct anatomy: a study of cadaveric and surgical specimens. J Urology
1996; 155: 1639–42.
Liu C, Song Z, Dun Y, Zhang S, Wang Z. [Transurethral electrotomy combined with seminal vesiculoscopy ejaculatory duct dilatation in treating patients with Mullerian duct cyst]. J Cent South Univ
2015; 40: 670–3. [Article in Chinese]
Wang H, Ye H, Xu C, Liu Z, Gao X, et al.
Transurethral seminal vesiculoscopy using a 6F vesiculoscope for ejaculatory duct obstruction: initial experience. J Androl
2012; 33: 637–43.
Cui ZQ, Wang YC, Du J, Zhou HJ, Yu ZY, et al.
[Transurethral seminal vesiculoscopy combined with finasteride for recurrent hematospermia]. Zhonghua Nan Ke Xue
2014; 20: 536–8. [Article in Chinese]
Tang SX, Zhou HL, Ding YL. [Effectiveness of transurethral seminal vesiculoscopy in the treatment of persistent hematospermia, and oligoasthenozoospermia and azoospermia from ejaculatory duct obstruction]. Zhonghua Yi Xue Za Zhi
2016; 96: 2872–5. [Article in Chinese]
Turek PJ, Aslam K, Younes AK, Nguyen HT. Observations on seminal vesicle dynamics in an in vivo
rat model. J Urol
1998; 159: 1731–4.
Christodoulidou M, Parnham A, Nigam R. Diagnosis and management of symptomatic seminal vesicle calculi. Scand J Urol
2017; 51: 237–44.